The relative safety of ephedra compared with other herbal products

被引:93
作者
Bent, S
Tiedt, TN
Odden, MC
Shlipak, MG
机构
[1] San Francisco VA Med Ctr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA
[3] Med Tox Grp, Longboat Key, FL USA
关键词
D O I
10.7326/0003-4819-138-6-200303180-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Ephedra is widely used in dietary supplements that are marketed to promote weight loss or increase energy; however, the safety of this product has been questioned because of numerous case reports of adverse events. Objective: To compare the risk for adverse events attributable to ephedra and other herbal products. Design: Comparative case series. Setting: American Association of Poison Control Centers Toxic Event Surveillance System Database Annual Report, 2001. Measurements: The relative risk and 95% confidence interval for experiencing an adverse reaction after ephedra. use compared with other herbs. This risk was defined as the ratio of adverse reactions to ephedra. versus other products, divided by the ratio of their relative use in the United States. Results: Products containing ephedra accounted for 64% of all adverse reactions to herbs in the United States, yet these products represented only 0.82% of herbal product sales. The relative risks for an adverse reaction in persons using ephedra compared with other herbs were extremely high, ranging from 100 (95% Cl, 83 to 140) for kava to 720 (Cl, 520 to 1100) for Ginkgo biloba. Conclusions: Ephedra use is associated with a greatly increased risk for adverse reactions compared with other herbs, and its use should be restricted.
引用
收藏
页码:468 / 471
页数:4
相关论文
共 16 条
[1]   Danger of the administration of ephedrine in heart failure [J].
Bloedorn, WA ;
Dickens, PF .
ARCHIVES OF INTERNAL MEDICINE, 1928, 42 (03) :322-330
[2]   An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial [J].
Boozer, CN ;
Nasser, JA ;
Heymsfield, SB ;
Wang, V ;
Chen, G ;
Solomon, JL .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (03) :316-324
[3]   Ephedrine and related substances [J].
Chen, KK ;
Schmidt, CF .
MEDICINE, 1930, 9 (01) :1-117
[4]  
FOSTER S., 1999, TYLER'S HONEST HERBAL: A SENSIBLE GUIDE TO THE USE OF HERBS AND RELATED REMEDIES, VFOURTH
[5]   Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (ma-huang) as determined by high performance liquid chromatography [J].
Gurley, BJ ;
Wang, P ;
Gardner, SF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (12) :1547-1553
[6]   Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. [J].
Haller, CA ;
Benowitz, NL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1833-1838
[7]  
Hardman JG, 2001, GOODMAN GILMANS PHAR, V10th
[8]  
KIMMEL SE, 2003, SUMMARY INCIDENCE SE
[9]   2001 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System [J].
Litovitz, TL ;
Klein-Schwartz, W ;
Rodgers, GC ;
Cobaugh, DJ ;
Youniss, J ;
Omslaer, JC ;
May, ME ;
Woolf, AD ;
Benson, BE .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2002, 20 (05) :391-452
[10]  
RICHMAN A, 2001, 7 ANN HERB SALES SUR, P23